Cargando…

The gene expression level of IFN-γR1 and IFN-γR2 in a murine model treated with Toxoplasma gondii and its products

AIM: To evaluate the effect of active T. gondii tachyzoites and its products on the gene expression level of IFN-γR1 and IFN-γR2 in a murine model. BACKGROUND: Many studies have shown that the parasite Toxoplasma gondii utilizes different mechanisms to inhibit the function of IFN-γ, but the parasite...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalani, Hamed, Khanahmad Shahreza, Hosein, Daryani, Ahmad, Yousefi, Hosein Ali, Pestechian, Nader, Mansouri, Vahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833851/
https://www.ncbi.nlm.nih.gov/pubmed/27099672
_version_ 1782427394472148992
author Kalani, Hamed
Khanahmad Shahreza, Hosein
Daryani, Ahmad
Yousefi, Hosein Ali
Pestechian, Nader
Mansouri, Vahid
author_facet Kalani, Hamed
Khanahmad Shahreza, Hosein
Daryani, Ahmad
Yousefi, Hosein Ali
Pestechian, Nader
Mansouri, Vahid
author_sort Kalani, Hamed
collection PubMed
description AIM: To evaluate the effect of active T. gondii tachyzoites and its products on the gene expression level of IFN-γR1 and IFN-γR2 in a murine model. BACKGROUND: Many studies have shown that the parasite Toxoplasma gondii utilizes different mechanisms to inhibit the function of IFN-γ, but the parasite effect on the function of IFN-γR1 and IFN-γR2 is still unclear. PATIENTS AND METHODS: Toxoplasma lysate product (TLP), excretory/secretory products (ESPs) obtained from cell free and cell culture media as well as active tachyzoites were injected separately to their respective group each consisted of 10 BALB/c mice. One control group of 10 mice received phosphate buffered saline (PBS). All of the mice were euthanized three days after the last injection and then their peritoneal leukocytes were harvested separately. The total RNA was extracted from the samples, converted to cDNA, and the gene expression level of IFN-γR1 and IFN-γR2 was assessed in all of the treated groups relative to the control one. RESULTS: There was no significant difference between each of the treated groups relative to the control group concerning the gene expression level of IFN-γR2 (P> 0.05). Furthermore, the gene expression level of IFN-γR1 in two groups of TLP (P= 0.04) and ESP obtained from cell free medium (P= 0.008) showed a significant difference relative to the control group. CONCLUSION: Findings of this study revealed a new aspect of host-T. gondii interaction in that this parasite is able to downregulate IFN-γR1 to reduce the IFN-γ effects on the infected cell.
format Online
Article
Text
id pubmed-4833851
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-48338512016-04-20 The gene expression level of IFN-γR1 and IFN-γR2 in a murine model treated with Toxoplasma gondii and its products Kalani, Hamed Khanahmad Shahreza, Hosein Daryani, Ahmad Yousefi, Hosein Ali Pestechian, Nader Mansouri, Vahid Gastroenterol Hepatol Bed Bench Original Article AIM: To evaluate the effect of active T. gondii tachyzoites and its products on the gene expression level of IFN-γR1 and IFN-γR2 in a murine model. BACKGROUND: Many studies have shown that the parasite Toxoplasma gondii utilizes different mechanisms to inhibit the function of IFN-γ, but the parasite effect on the function of IFN-γR1 and IFN-γR2 is still unclear. PATIENTS AND METHODS: Toxoplasma lysate product (TLP), excretory/secretory products (ESPs) obtained from cell free and cell culture media as well as active tachyzoites were injected separately to their respective group each consisted of 10 BALB/c mice. One control group of 10 mice received phosphate buffered saline (PBS). All of the mice were euthanized three days after the last injection and then their peritoneal leukocytes were harvested separately. The total RNA was extracted from the samples, converted to cDNA, and the gene expression level of IFN-γR1 and IFN-γR2 was assessed in all of the treated groups relative to the control one. RESULTS: There was no significant difference between each of the treated groups relative to the control group concerning the gene expression level of IFN-γR2 (P> 0.05). Furthermore, the gene expression level of IFN-γR1 in two groups of TLP (P= 0.04) and ESP obtained from cell free medium (P= 0.008) showed a significant difference relative to the control group. CONCLUSION: Findings of this study revealed a new aspect of host-T. gondii interaction in that this parasite is able to downregulate IFN-γR1 to reduce the IFN-γ effects on the infected cell. Shaheed Beheshti University of Medical Sciences 2016 /pmc/articles/PMC4833851/ /pubmed/27099672 Text en ©2016 RIGLD, Research Institute for Gastroenterology and Liver Diseases This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kalani, Hamed
Khanahmad Shahreza, Hosein
Daryani, Ahmad
Yousefi, Hosein Ali
Pestechian, Nader
Mansouri, Vahid
The gene expression level of IFN-γR1 and IFN-γR2 in a murine model treated with Toxoplasma gondii and its products
title The gene expression level of IFN-γR1 and IFN-γR2 in a murine model treated with Toxoplasma gondii and its products
title_full The gene expression level of IFN-γR1 and IFN-γR2 in a murine model treated with Toxoplasma gondii and its products
title_fullStr The gene expression level of IFN-γR1 and IFN-γR2 in a murine model treated with Toxoplasma gondii and its products
title_full_unstemmed The gene expression level of IFN-γR1 and IFN-γR2 in a murine model treated with Toxoplasma gondii and its products
title_short The gene expression level of IFN-γR1 and IFN-γR2 in a murine model treated with Toxoplasma gondii and its products
title_sort gene expression level of ifn-γr1 and ifn-γr2 in a murine model treated with toxoplasma gondii and its products
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833851/
https://www.ncbi.nlm.nih.gov/pubmed/27099672
work_keys_str_mv AT kalanihamed thegeneexpressionlevelofifngr1andifngr2inamurinemodeltreatedwithtoxoplasmagondiianditsproducts
AT khanahmadshahrezahosein thegeneexpressionlevelofifngr1andifngr2inamurinemodeltreatedwithtoxoplasmagondiianditsproducts
AT daryaniahmad thegeneexpressionlevelofifngr1andifngr2inamurinemodeltreatedwithtoxoplasmagondiianditsproducts
AT yousefihoseinali thegeneexpressionlevelofifngr1andifngr2inamurinemodeltreatedwithtoxoplasmagondiianditsproducts
AT pestechiannader thegeneexpressionlevelofifngr1andifngr2inamurinemodeltreatedwithtoxoplasmagondiianditsproducts
AT mansourivahid thegeneexpressionlevelofifngr1andifngr2inamurinemodeltreatedwithtoxoplasmagondiianditsproducts
AT kalanihamed geneexpressionlevelofifngr1andifngr2inamurinemodeltreatedwithtoxoplasmagondiianditsproducts
AT khanahmadshahrezahosein geneexpressionlevelofifngr1andifngr2inamurinemodeltreatedwithtoxoplasmagondiianditsproducts
AT daryaniahmad geneexpressionlevelofifngr1andifngr2inamurinemodeltreatedwithtoxoplasmagondiianditsproducts
AT yousefihoseinali geneexpressionlevelofifngr1andifngr2inamurinemodeltreatedwithtoxoplasmagondiianditsproducts
AT pestechiannader geneexpressionlevelofifngr1andifngr2inamurinemodeltreatedwithtoxoplasmagondiianditsproducts
AT mansourivahid geneexpressionlevelofifngr1andifngr2inamurinemodeltreatedwithtoxoplasmagondiianditsproducts